DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by DiaMedica Therapeutics Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for DiaMedica Therapeutics Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Pauls Dietrich John | President & CEO | 128,791 | Aug 12, 2026 | 2 |
| Kuntz Richard | Director | 24,210 | Jun 3, 2026 | 1 |
| O'Connor Daniel J. | Director | – | Jun 3, 2026 | 1 |
| Lewis Tanya | Director | – | Jun 3, 2026 | 1 |
| Kellen Scott | CFO & Secretary | 32,290 | Jun 3, 2026 | 1 |
| Krop Julie | Chief Medical Officer | – | Jun 3, 2026 | 2 |
| Giuffre Randall Michael | Director | 398,587 | Jun 3, 2026 | 2 |
| Parsons James T. | Director | 97,949 | Jun 3, 2026 | 3 |
| Semba Charles Pauling | Director | 47,963 | Jun 3, 2026 | 2 |
| Trill AB | 10% Owner | 8,825,742Indirect | Dec 8, 2025 | 1 |
| Stahlberg Jan | 10% Owner | 8,825,742Indirect | Dec 8, 2025 | 1 |
| TomEnterprise AB | 10% Owner | 8,383,577Indirect | Jul 25, 2025 | 0 |
| Von Koch Thomas | 10% Owner | 8,383,577Indirect | Jul 25, 2025 | 0 |
| TomEnterprise Private AB | 10% Owner | 8,383,577Indirect | Jul 25, 2025 | 0 |
| Jacinto Richard II | 10% Owner | 4,958,823Indirect | Jul 25, 2025 | 0 |
| Wambeke David J. | Chief Business Officer | 527,114 | Jun 3, 2025 | 0 |
| Pilnik Richard D. | Director | 312,995 | Apr 8, 2025 | 0 |
| Cundari Dominic R | Chief Commercial Officer | – | Jun 3, 2024 | 0 |
| Lorianne Masuoka K. | Chief Medical Officer | – | Jan 23, 2024 | 0 |
| Gruis Kirsten L | Chief Medical Officer | – | Jun 2, 2023 | 0 |
| Daves Julie VanOrsdel | SVP Clinical Development Oper. | – | Jun 2, 2023 | 0 |
| Burroughs Amy L. | Director | 73,288 | Jan 3, 2023 | 0 |
| Alcorn Harry W Jr | SVP, Clinical Operations | 43,582 | Sep 15, 2021 | 0 |
| Gilman Sydney A. | VP, Regulatory Affairs | – | Jul 29, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Kellen ScottCFO and Secretary | PPurchaseVoting Common Shares, no par value per share | +10.0K | $3.15 | +$31.5K | +81.4%22.3K after | |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Pauls Dietrich JohnPresident and CEO | PPurchaseVoting Common Shares, no par value per share | +5.00K | $3.14 | +$15.7K | +16.2%35.8K after | |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Alcorn Harry W JrSenior VP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +20.3K | $3.09 | +$62.8K | +246.0%28.6K after | 2 lots |
| Aug 16, 2021 (view filing) | Aug 16 | Same day | Alcorn Harry W JrSenior VP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +399 | $3.07 | +$1.22K | New position399 after | |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Pilnik Richard D.Director | PPurchaseVoting Common Shares, no par value per share | +15.0K | $3.27 | +$49.0K | +18.6%95.6K after | 2 lots |
| Aug 17, 2021 (view filing) | Aug 16 | 1 day | Burroughs Amy L.Director | PPurchaseVoting Common Shares, no par value per share | +45.0K | $3.15 | +$141.6K | New position45.0K after | |
| Sep 15, 2021 (view filing) | Sep 15 | Same day | Alcorn Harry W JrSVP, Clinical Operations | PPurchaseVoting Common Shares, no par value per share | +15.0K | $3.80 | +$57.0K | +52.5%43.6K after | |
| Jul 21, 2022 (view filing)1:06 PM ET | Jul 8 | 13 daysLate | TomEnterprise AB and 1 other10% Owner | PPurchase | +208.0K | $1.33 | +$275.9K | +7.9%2.86M after | |
| Nov 16, 2022 (view filing) | Nov 16 | Same day | Pauls Dietrich JohnPresident and CEO | PPurchaseVoting Common Shares, no par value per share | +20.0K | $1.21 | +$24.2K | +55.9%55.8K after | |
| Dec 1, 2022 (view filing) | Nov 29-Dec 1 | 2 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +67.2K | $1.20 | +$80.5K | +61.0%177.5K after | 3 lots |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +819 | $1.19 | +$974.61 | +0.5%178.3K after | |
| Dec 5, 2022 (view filing) | Dec 5 | Same day | Pilnik Richard D.Director | PPurchaseVoting Common Shares, no par value per share | +35.0K | $1.39 | +$48.6K | +29.3%154.3K after | |
| Dec 6, 2022 (view filing)3:19 PM ET | Dec 2 | 4 days | TomEnterprise AB and 2 others10% Owner | SSale | −2.86M | $1.24 | −$3.53M | −100.0%0 after | |
| Dec 6, 2022 (view filing)3:19 PM ET | Dec 2 | 4 days | TomEnterprise AB and 2 others10% Owner | PPurchase | +2.86M | $1.24 | +$3.53M | New position2.86M after | |
| Dec 8, 2022 (view filing) | Dec 6-7 | 2 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +24.9K | $1.40 | +$34.7K | +14.0%203.1K after | 2 lots |
| Dec 12, 2022 (view filing) | Dec 8-9 | 4 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +57.1K | $1.42 | +$81.0K | +28.1%260.2K after | 2 lots |
| Apr 11, 2023 (view filing) | Apr 10 | 1 day | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +468.8K | $1.60 | +$750.0K | New position468.8K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Pilnik Richard D.Director | PPurchaseVoting Common Shares, no par value per share | +38.4K | $3.91 | +$150.0K | +18.3%248.2K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +38.4K | $3.91 | +$150.0K | +8.2%507.1K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Kellen ScottCFO and Secretary | PPurchaseVoting Common Shares, no par value per share | +10.0K | $3.91 | +$39.1K | +44.9%32.3K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Semba Charles PaulingDirector | PPurchaseVoting Common Shares, no par value per share | +12.8K | $3.91 | +$50.0K | +74.5%29.9K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Pauls Dietrich JohnPresident and CEO | PPurchaseVoting Common Shares, no par value per share | +12.8K | $3.91 | +$50.0K | +22.9%68.6K after | |
| Jun 26, 2023 (view filing) | Jun 23 | 3 days | Giuffre Randall MichaelDirector | PPurchaseVoting Common Shares, no par value per share | +65.0K | $3.91 | +$254.2K | +22.0%360.4K after | |
| Jun 27, 2023 (view filing)4:11 PM ET | Jun 23 | 4 days | TomEnterprise AB and 2 others10% Owner | PPurchase | +1.47M | $3.40 | +$5.00M | +51.5%4.33M after | |
| Nov 16, 2023 (view filing) | Nov 16 | Same day | Wambeke David J.Chief Business Officer | PPurchaseVoting Common Shares, no par value per share | +20.0K | $2.46 | +$49.2K | +3.9%527.1K after | |
| Jul 1, 2024 (view filing)4:24 PM ET | Jun 28 | 3 days | Trill AB and 1 other10% Owner | PPurchase | +1.20M | $2.50 | +$3.00M | +29.8%5.22M after | |
| Jul 1, 2024 (view filing)4:27 PM ET | Jun 28 | 3 days | TomEnterprise AB and 2 others10% Owner | PPurchase | +1.20M | $2.50 | +$3.00M | +27.7%5.53M after | |
| Jul 25, 2025 (view filing) | Jul 23 | 2 days | Jacinto Richard II10% Owner | PPurchaseVoting Common Shares, no par value per share | +400.0K | $3.50 | +$1.40M | +8.8%4.96M after | |
| Jul 25, 2025 (view filing)5:49 PM ET | Jul 23 | 2 days | TomEnterprise AB and 2 others10% Owner | PPurchase | +2.86M | $3.50 | +$10.0M | +51.7%8.38M after | |
| Jul 25, 2025 (view filing)6:54 PM ET | Jul 23 | 2 days | Trill AB and 1 other10% Owner | PPurchase | +1.54M | $3.50 | +$5.40M | +29.5%6.76M after | |
| Sep 4, 2025 (view filing)2:29 PM ET | Aug 13-27 | 22 daysLate | Trill AB and 1 other10% Owner | PPurchase | +1.00M | $5.96 | +$5.96M | +14.8%7.76M after | 9 lots |
| Dec 8, 2025 (view filing)5:15 PM ET | Nov 17-25 | 21 daysLate | Trill AB and 1 other10% Owner | PPurchase | +1.06M | $7.19 | +$7.63M | +13.7%8.83M after | 7 lots |